Update on the current opinion, status and future development of digital pathology in Switzerland in light of COVID-19

Viktor Hendrik Koelzer; Rainer Grobholz; Inti Zlobec; Andrew Janowczyk

doi:10.1136/jclinpath-2021-207768

Article info

PDF

PDF +
Supplementary
Material

Original research

Update on the current opinion, status and future development of digital pathology in Switzerland in light of COVID-19

Authors

Viktor Hendrik Koelzer Medical Faculty, University of Zurich, Zurich, Switzerland Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland PubMed articles Google scholar articles
Rainer Grobholz Medical Faculty, University of Zurich, Zurich, Switzerland Institute of Pathology, Kantonsspital Aarau, Aarau, Switzerland PubMed articles Google scholar articles
Inti Zlobec Institute of Pathology, University of Bern, Bern, Switzerland PubMed articles Google scholar articles
Andrew Janowczyk Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland Biomedical Engineering Department, Case Western Reserve University, Cleveland, Ohio, USA PubMed articles Google scholar articles
On behalf of Swiss Digital Pathology Consortium (SDiPath)
Google scholar articles

Correspondence to Professor Viktor Hendrik Koelzer, Medical Faculty, University of Zurich, Zurich 8006, Switzerland; viktor.koelzer{at}usz.ch

View Full Text

Citation

Koelzer VH, Grobholz R, Zlobec I On behalf of Swiss Digital Pathology Consortium (SDiPath), et al

Update on the current opinion, status and future development of digital pathology in Switzerland in light of COVID-19

Journal of Clinical Pathology 2022;75:687-689.

Publication history

Received June 16, 2021
Accepted July 20, 2021
First published September 13, 2021.

Online issue publication

September 19, 2022

Article Versions

Previous version (13 September 2021).
Previous version (16 May 2022).
Previous version (29 June 2022).
You are viewing the most recent version of this article.

Supplementary Data

This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Data supplement 1
Data supplement 2
Data supplement 3
Data supplement 4
Supplementary Data

This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Data supplement 1
Data supplement 2
Data supplement 3
Data supplement 4
Supplementary Data

This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Data supplement 1
Data supplement 2
Data supplement 3
Data supplement 4

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Supplementary Data

Supplementary Data

Supplementary Data

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password